138 related articles for article (PubMed ID: 9154180)
1. Clinical development plan: sulindac sulfone.
J Cell Biochem Suppl; 1996; 26():227-35. PubMed ID: 9154180
[No Abstract] [Full Text] [Related]
2. Clinical development plan: 13-cis-retinoic acid.
J Cell Biochem Suppl; 1996; 26():168-201. PubMed ID: 9154177
[No Abstract] [Full Text] [Related]
3. Clinical development plan: vitamin A.
J Cell Biochem Suppl; 1996; 26():269-307. PubMed ID: 9154183
[No Abstract] [Full Text] [Related]
4. Clinical development plan: 1,4-penylenebis(methylene)selenocyanate.
J Cell Biochem Suppl; 1996; 26():219-26. PubMed ID: 9154179
[No Abstract] [Full Text] [Related]
5. Clinical development plan: dehydroepiandrosterone (DHEA).
J Cell Biochem Suppl; 1996; 26():86-99. PubMed ID: 9154170
[No Abstract] [Full Text] [Related]
6. Clinical development plan: (+)-vorozole.
J Cell Biochem Suppl; 1996; 26():308-15. PubMed ID: 9154184
[No Abstract] [Full Text] [Related]
7. Clinical development plan: l-Selenomethionine.
J Cell Biochem Suppl; 1996; 26():202-18. PubMed ID: 9154178
[No Abstract] [Full Text] [Related]
8. Clinical development plan: curcumin.
J Cell Biochem Suppl; 1996; 26():72-85. PubMed ID: 9154169
[No Abstract] [Full Text] [Related]
9. Clinical development plan: genistein.
J Cell Biochem Suppl; 1996; 26():114-26. PubMed ID: 9154172
[No Abstract] [Full Text] [Related]
10. Clinical development plan: phenethyl isothiocyanate.
J Cell Biochem Suppl; 1996; 26():149-57. PubMed ID: 9154175
[No Abstract] [Full Text] [Related]
11. Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.
J Cell Biochem Suppl; 1996; 26():236-57. PubMed ID: 9154181
[No Abstract] [Full Text] [Related]
12. Clinical development plan: indole-3-carbinol.
J Cell Biochem Suppl; 1996; 26():127-36. PubMed ID: 9154173
[No Abstract] [Full Text] [Related]
13. Clinical development plan: folic acid.
J Cell Biochem Suppl; 1996; 26():100-13. PubMed ID: 9154171
[No Abstract] [Full Text] [Related]
14. Clinical development plan: sulindac.
Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
J Cell Biochem Suppl; 1994; 20():240-51. PubMed ID: 7616747
[No Abstract] [Full Text] [Related]
15. Clinical development plan: ursodiol.
J Cell Biochem Suppl; 1996; 26():258-68. PubMed ID: 9154182
[No Abstract] [Full Text] [Related]
16. Exisulind shows positive results in the prevention of precancerous colon polyps.
Oncology (Williston Park); 2000 May; 14(5):772-3. PubMed ID: 10853464
[No Abstract] [Full Text] [Related]
17. Clinical development plan: 9-cis-retinoic acid.
J Cell Biochem Suppl; 1996; 26():158-67. PubMed ID: 9154176
[No Abstract] [Full Text] [Related]
18. Clinical development plan: l-perillyl alcohol.
J Cell Biochem Suppl; 1996; 26():137-48. PubMed ID: 9154174
[No Abstract] [Full Text] [Related]
19. [Role of suindac in the treatment of familial adenomatous polyposis coli].
Landauer S; Halimi C; Caulin C; Bergmann JF
Therapie; 1999; 54(6):675-82. PubMed ID: 10709439
[TBL] [Abstract][Full Text] [Related]
20. Clinical development plan: oltipraz.
Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
J Cell Biochem Suppl; 1994; 20():205-18. PubMed ID: 7616744
[No Abstract] [Full Text] [Related]
[Next] [New Search]